Amorolfine

BNF:

13.10.2

Status:

Grey

Decision Date:

February 2014

Comments

GREY: Restricted use for fungal nail infections where systemic therapy is indicated but contraindicated. Not for cosmetic purposes.

Brown Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy
• 7: Not accepted as cost effective compared to other service development opportunities within the CCGs

search again